MS4A1 and B-cell acute lymphoblastic leukemia: <h4>Introduction</h4>The B-cell-specific marker CD20 is expressed in various B-cell malignancies, including B-cell acute lymphoblastic leukemia (B-ALL) and serves as a key target for immunotherapies.